Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
mybacs logo — Support gut health with one capsule a day. Do it daily to bo...

mybacs

Support gut health with one capsule a day. Do it daily to boost digestion, energy, and overall wellness.

Founded 2019 Switzerland Zug, Switzerland 66 employees Series A Total: $5.90M Biotechnology, Pharmaceutical

General Information

Company Name mybacs
Founded Year 2019
Location Switzerland Zug, Switzerland
Founders / Decision Makers
Team member
Employees 66
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Business Model D2C, E Commerce, Subscription Box
Revenue Model Subscription, Product Sales, One Time Purchase
Offices as of Oct 2026
Zug, Switzerland
Social

BounceWatch is an independent company data service, not affiliated with mybacs. To contact mybacs, visit mybacs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does mybacs compare?

A PDF of mybacs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting mybacs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Pivot Announced Oct 14, 2026

mybacs underwent a significant pivot, transitioning from a non-functional business model to a successful brand now present in major retail stores like dm and Rossmann.

Major Customer Win Oct 12, 2026

mybacs secured a major retail customer win with premium department store Alsterhaus, which will now carry mybacs products.

Homepage Update

Significant changes detected on company website (35.6% content change).

Get alerts when mybacs shows new signals

AI Insight

Bounce Watch AI
2 weeks ago

mybacs demonstrates sustained, strong growth in the DACH & CEE region, earning recognition as a fast-growing startup for the third consecutive year. This proven market traction is coupled with a recent significant website overhaul, suggesting an active optimization of their direct-to-consumer strategy, potential new product launches, or preparation for broader market expansion to capitalize on their growth momentum.

Signal Types
Growth Recognition Product Update
Strategic Labels
DTC Optimization Market Leadership Digital Strategy
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: Series B Investors — Digital Health & Nutraceuticals

About mybacs

mybacs is a research-driven direct-to-consumer company specializing in the human microbiome, headquartered in Zug, Switzerland. It caters to individuals interested in gut health and health-conscious consumers, offering synbiotic supplements tailored to their needs.

Founded in 2019, mybacs focuses on probiotic supplements, prebiotic products, and nutritional drinks, supported by a team of pharmaceutical scientists and physicians. The company operates through a D2C and e-commerce business model, with revenue generated from subscriptions, product sales, and one-time purchases. Its product range includes synbiotic supplements and educational resources about health and wellness available via an online shopping platform.

Business keywords: Gut Health, Microbiome, Intestinal Healthcare, Synbiotic Supplements, Probiotic Cultures, Prebiotics, Pharmaceutical Science, Direct-to-Consumer, Personalized Nutrition, Research-Driven, Wellness Products, Multi-Species Probiotics, Healthcare Innovation, Dietary Supplements, Well-being Enhancement

Services & Products

Probiotic Supplements
Prebiotic and Postbiotic Products
Nutritional Drinks
Health and Wellness Education
Online Shopping Platform

Target Customers

Women seeking health supplements Individuals interested in gut health Health-conscious consumers Returning customers through loyalty programs

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $5.90M 4
Joyance Partners Seven Ventures WENVEST Capital
Joyance Partners, Seven Ventures +2
01 Oct 2023
Media For Equity Undisclosed 1
Commerce and Ventures(SevenVentures)
01 Jan 2021
Seed Undisclosed 2
Joyance Partners Global Founders Capital
Joyance Partners, Global Founders Capital
01 Jul 2020
Seed Undisclosed 1
Global Founders Capital
Global Founders Capital
01 Aug 2019

Latest News

View All
€100 million for VC naturalX Health Ventures to fuel consumer health in Europe — Eu-startups
€100 million for VC naturalX Health Ventures to fuel consumer health in Europe
Eu-startups Feb 17, 2025
naturalX announces €100M fund for consumer health startups — Tech
naturalX announces €100M fund for consumer health startups
Tech Feb 17, 2025

mybacs Alternatives & Competitors

View All Alternatives
mybacs vs
Arkopharma
Arkopharma France

Faire de la Médecine Naturelle la Médecine de Demain.

831 employees
Biotechnology, Pharmaceutical
Compare mybacs vs Arkopharma
mybacs vs
Xbiome
Xbiome United States

China's leading AI-driven microbiome drug development company

Series B
51 employees
AI, Biotechnology
Compare mybacs vs Xbiome
mybacs vs
Welmedix Consumer Healthcare
Welmedix Consumer Healthcare

Innovative healthcare solutions enhancing well-being since 2005, based in Princeton, New Jersey.

Venture round
Biotechnology, Health Care
View all alternatives

FAQ About mybacs

Support gut health with one capsule a day. Do it daily to boost digestion, energy, and overall wellness.
mybacs was founded in 2019.
mybacs is headquartered in Zug, Switzerland.
mybacs operates in Biotechnology and Pharmaceutical. Its work centres on Gut Health, Microbiome, Intestinal Healthcare and Synbiotic Supplements. Its customers include Women seeking health supplements, Individuals interested in gut health and Health-conscious consumers.
mybacs has a D2C, E Commerce and Subscription Box business model. Its revenue comes from Subscription, Product Sales and One Time Purchase.
mybacs has approximately 66 employees.
mybacs has completed 4 funding rounds, raising a total of $5.90M. The latest funding stage is Series A.
mybacs offers: Probiotic Supplements, Prebiotic and Postbiotic Products, Nutritional Drinks, Health and Wellness Education, Online Shopping Platform.
Top alternatives and competitors to mybacs include Arkopharma, Xbiome, Welmedix Consumer Healthcare, Mimio Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
mybacs and Arkopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for mybacs, https://bouncewatch.com/company/mybacs, updated 10 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes